CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleMarket cap is $1.21B, above the global median of $1.15B
- PositionProfit margin is -29.1%, lower than 95% of its Medical Instruments & Supplies peers (median 7.4%)
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.21BUSDvs all stocks (USD)
Revenue (TTM)
596.48MUSDvs all stocks (USD)
Profit Margin
-29.06%vs Medical Instruments & Supplies peers
Beta
1.37xvs all stocks
52-Week Change
-16.06%vs all stocks
Market Capitalization
1.21BUSDvs all stocks (USD)
Enterprise Value
909.56MUSDvs all stocks (USD)
Forward P/E
43.62xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
2.07xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
0.7940xvs Medical Instruments & Supplies peers
Enterprise to Revenue
1.52xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
24.77xvs Medical Instruments & Supplies peers
Gross Margin
42.84%vs Medical Instruments & Supplies peers
Profit Margin
-29.06%vs Medical Instruments & Supplies peers
Operating Margin
-10.56%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
-0.64%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
-6.81%vs Medical Instruments & Supplies peers
Revenue (TTM)
596.48MUSDvs all stocks (USD)
Revenue per Share (TTM)
12.99USDUpdated Jul 18, 2026Quarterly Revenue Growth
1.00%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
264.42MUSDvs all stocks (USD)
EBITDA (TTM)
190.06MUSDvs all stocks (USD)
Net Income (TTM)
-110.89MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
0.96%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
62.34MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
101.33MUSDvs all stocks (USD)
5-Year Average Dividend Yield
0.83%vs all stocks
Payout Ratio
0.00%vs Medical Instruments & Supplies peers
Revenue
593.82MUSDFY2025 · Sep 30, 2025Cost of Goods Sold
323.54MUSDFY2025 · Sep 30, 2025Gross Profit
270.28MUSDFY2025 · Sep 30, 2025Operating Income
-21.67MUSDvs all stocks (USD)
Pre-tax Income
-7.14MUSDFY2025 · Sep 30, 2025Income Tax Expense
-31.60MUSDFY2025 · Sep 30, 2025Net Income
-55.76MUSDFY2025 · Sep 30, 2025EBIT
-21.67MUSDFY2025 · Sep 30, 2025EBITDA (Income Statement)
44.71MUSDFY2025 · Sep 30, 2025Research & Development
30.39MUSDFY2025 · Sep 30, 2025Selling, General & Administrative
261.56MUSDFY2025 · Sep 30, 2025Non-operating Interest Income
18.78MUSDFY2025 · Sep 30, 2025EPS (Basic)
-1.30USDFY2025 · Sep 30, 2025EPS (Diluted)
-1.30USDFY2025 · Sep 30, 2025Basic Shares Outstanding
45.74MSharesFY2025 · Sep 30, 2025Diluted Shares Outstanding
45.74MSharesFY2025 · Sep 30, 2025Net Income from Continuing Operations
-55.76MUSDFY2025 · Sep 30, 2025Operating Cash Flow
-30.54MUSDFY2025 · Sep 30, 2025Free Cash Flow
-64.40MUSDFY2025 · Sep 30, 2025Cash & Cash Equivalents (End of Period)
296.69MUSDFY2025 · Sep 30, 2025Income Tax Paid
6.57MUSDFY2025 · Sep 30, 2025Starting Profit (CF Statement)
-55.76MUSDFY2025 · Sep 30, 2025Depreciation & Amortization
61.21MUSDFY2025 · Sep 30, 2025Deferred Taxes (CF)
-27.04MUSDFY2025 · Sep 30, 2025Stock-based Compensation
20.88MUSDFY2025 · Sep 30, 2025Change in Accounts Receivable (CF)
-24.56MUSDFY2025 · Sep 30, 2025Change in Accounts Payable (CF)
1.04MUSDFY2025 · Sep 30, 2025Change in Other Assets/Liabilities
-6.30MUSDFY2025 · Sep 30, 2025Capital Expenditures
-33.86MUSDFY2025 · Sep 30, 2025Net Acquisitions
0.00USDFY2025 · Sep 30, 2025Purchase of Investments
-451.41MUSDFY2025 · Sep 30, 2025Sale of Investments
394.81MUSDFY2025 · Sep 30, 2025Net Investing Cash Flow
-90.46MUSDFY2025 · Sep 30, 2025Long-term Debt Payments
-985.00KUSDFY2025 · Sep 30, 2025Common Stock Repurchase
0.00USDFY2025 · Sep 30, 2025Other Financing Charges
-11.38MUSDFY2025 · Sep 30, 2025Net Financing Cash Flow
-9.59MUSDFY2025 · Sep 30, 2025Shares Outstanding
46.09MSharesUpdated Jul 18, 2026Float Shares
40.60MSharesUpdated Jul 18, 2026Shares Short
6.22MSharesUpdated Jul 18, 2026Short Ratio
7.12daysvs all stocks
Short % of Shares Outstanding
21.25%vs all stocks
% Held by Insiders
1.00%vs all stocks
% Held by Institutions
116.86%vs all stocks
Total Cash (MRQ)
380.52MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
8.26USDUpdated Jul 18, 2026Total Debt (MRQ)
55.71MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.0358xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
2.83xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
33.73USDUpdated Jul 18, 2026Total Assets
2.06BUSDvs all stocks (USD)
Total Current Assets
708.34MUSDFY2025 · Sep 30, 2025Total Liabilities
332.60MUSDFY2025 · Sep 30, 2025Total Non-current Assets
1.35BUSDFY2025 · Sep 30, 2025Total Non-current Liabilities
94.92MUSDFY2025 · Sep 30, 2025Total Current Liabilities
237.67MUSDFY2025 · Sep 30, 2025Cash & Cash Equivalents
279.78MUSDFY2025 · Sep 30, 2025Other Short-term Investments
61.14MUSDFY2025 · Sep 30, 2025Accounts Receivable
142.18MUSDFY2025 · Sep 30, 2025Inventory
74.96MUSDFY2025 · Sep 30, 2025Accounts Payable
37.72MUSDFY2025 · Sep 30, 2025Deferred Revenue
58.07MUSDFY2025 · Sep 30, 2025Other Current Liabilities
61.69MUSDFY2025 · Sep 30, 2025Long-term Debt
51.24MUSDFY2025 · Sep 30, 2025Other Non-current Liabilities
11.14MUSDFY2025 · Sep 30, 2025Common Stock (Book)
594.00KUSDFY2025 · Sep 30, 2025Retained Earnings
1.42BUSDFY2025 · Sep 30, 2025Total Shareholders' Equity
1.73BUSDvs all stocks (USD)
Treasury Stock
200.96MUSDFY2025 · Sep 30, 202552-Week Low
15.93USDUpdated Jul 18, 202652-Week High
41.73USDUpdated Jul 18, 202652-Week Change
-16.06%vs all stocks
Beta
1.37xvs all stocks
50-Day MA
22.39USDUpdated Jul 18, 2026200-Day MA
28.22USDUpdated Jul 18, 2026Avg 10-Day Volume
618.10KSharesUpdated Jul 18, 2026Avg 30-Day Volume
766.36KSharesUpdated Jul 18, 2026Diluted EPS (TTM)
-2.41USDUpdated Jul 18, 2026Other Income / Expense
-4.25MUSDFY2025 · Sep 30, 20251 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Profit margin is -29.1%, lower than 95% of its Medical Instruments & Supplies peers (median 7.4%)Significant
Profit margin: -0.29Industry median: 0.07Industry P5: -0.21Peers compared: 35.00
Price-to-book is 0.79×, lower than 95% of its Medical Instruments & Supplies peers (median 3.66×)Notable
Price-to-book: 0.79Industry median: 3.66Industry P5: 1.01Peers compared: 35.00
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.43Profit Margin: -0.29
Financial Health
Altman Z-Score 3.68: safe zoneNotable
Altman Z-Score: 3.68
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $1.21B, above the global median of $1.15BNotable
Market cap (USD): 1,211,779,817Global Median: 1,146,734,693.424
Revenue is $596.48M, above the global median of $520.53MNotable
Revenue (USD): 596,483,968Global Median: 520,528,949.311
Levered free cash flow is $101.33M, above the global median of $16.24MNotable
Levered free cash flow (USD): 101,328,000Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Chengdu Haoneng Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
NPK International Inc.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Zhejiang Jingu Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Zbit Semiconductor Inc.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
PureCycle Technologies Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Anhui Hwasu Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Ribo Fashion Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowAttention
Hunan Corun New Energy Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingFlow
Henan Thinker Automatic Equipment Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Lanzhou LS Heavy Equipment Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Companies that share active interpretations — structural patterns currently present in both stocks.
Adma Biologics Inc.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Weaver Network Technology Co., Ltd.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
AMC Entertainment Holdings, Inc.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated